SVA 3Cpro utilizes its protease activity to cleave STAT1 and STAT2, resulting in reduced phosphorylation of STAT1 and STAT2, which further disrupting the formation and nuclear translocation of ISGF3 complex, consequently diminishing IFN mediated antiviral response, ultimately benefiting SVA infection. The gene discussed is IFNA1; the disease is infection.